Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacotherapy for alcohol misuse: Views of patients, providers, and leaders in an Alaska Native healthcare system.

Journal of substance use and addiction treatment·2026
Same author

Attitudes About Alcohol Misuse Among Alaska Native People in a Tribal Health Care System.

Journal of addiction medicine·2025
Same author

Ethics of Predicting and Preventing Preterm Birth.

Clinics in perinatology·2024
Same author

Genetic research within Indigenous communities: Engagement opportunities and pathways forward.

Genetics in medicine : official journal of the American College of Medical Genetics·2024
Same author

African immigrants' favorable preterm birth rates challenge genetic etiology of the Black-White disparity in preterm birth.

Frontiers in public health·2024
Same author

Genetic Architecture of Dilated Cardiomyopathy in Individuals of African and European Ancestry.

JAMA·2023
Same journal

Optimizing reporting and outreach for surveillance and risk-reducing surgeries for cancer genetic predisposition: Findings of a workshop organized by the International Cascade Consortium.

Public health genomics·2026
Same journal

Key outcomes from a stakeholder workshop on genomic newborn screening: recommended next steps for the integration of genomics into public health programs.

Public health genomics·2026
Same journal

The IMPACT-FH Renewal Protocol: Evaluating FH Cascade Testing Implementation in Primary Care through a Pragmatic Trial, Economic Evaluation, and Mixed-Methods Sustainability Assessment.

Public health genomics·2026
Same journal

Hereditary Hemochromatosis and Hypertrophic Cardiomyopathy as Tier 1 Genomic Conditions: Implications for Adult Population Genomic Screening.

Public health genomics·2026
Same journal

Family Leaders Navigate Burden to Communicate Risk During Cascade Screening after Sudden Cardiac Death in the Young.

Public health genomics·2026
Same journal

Adolescent and Young Adult Perspectives on Receiving Pathogenic or Likely Pathogenic Results in a Prospective Genomic Screening Clinical Trial.

Public health genomics·2026
See all related articles

Related Experiment Videos

Debating clinical utility.

Wylie Burke1, A-M Laberge, N Press

  • 1Department of Bioethics and Humanities, University of Washington, Seattle, Wash. 98195-7120, USA. wburke@u.washington.edu

Public Health Genomics
|April 17, 2010
PubMed
Summary
This summary is machine-generated.

Determining the clinical utility of genetic tests involves contested values and evidence standards. Policy-making must address stakeholder perspectives on health and social outcomes for effective genetic testing implementation.

Related Experiment Videos

Area of Science:

  • Health Policy
  • Genetic Testing
  • Clinical Utility

Background:

  • Clinical utility of genetic tests is crucial for determining their value.
  • Assessing this value is often contentious due to differing stakeholder perspectives on benefits, risks, and outcomes.

Purpose of the Study:

  • To define key issues in policy-making for genetic test utility.
  • To highlight the importance of stakeholder values and deliberative methods.

Main Methods:

  • Analysis of stakeholder disagreements regarding evidence standards and outcome importance.
  • Identification of critical policy considerations for genetic test implementation.

Main Results:

  • Disagreements often stem from differing views on what evidence matters and how it should be interpreted.
  • Key issues include evidence standards, goals of screening programs, and funding for non-medical uses.

Conclusions:

  • Effective policy requires understanding stakeholder values and incorporating diverse perspectives (consumers, health professionals).
  • Addressing evidence standards, social outcomes, and appropriate uses is vital for equitable and valuable genetic testing.